Allison Elliott-Shannon

By

College: Medicine

Study Shows New Drug Compound Reduces Alzheimer's Pathology in Animal Model

Published: Jul 25, 2012

 

LEXINGTON, Ky. (July 25, 2012) — In a study published in the Journal of Neuroscience, a collaborative team of researchers led by Linda J. Van Eldik, director of the University of Kentucky Sanders-Brown Center on Aging, and D. Martin Watterson of the Northwestern University Feinberg School of Medicine, present results showing that a new central nervous system drug compound can reduce Alzheimer’s pathology in a mouse model of the disease.

 

The drug, called MW-151, is a selective suppressor of brain inflammation and overproduction of proinflammatory molecules from glial cells. The drug can be taken by mouth and readily enters the brain. The new study tested the hypothesis that intervention with drugs like MW-151 could be effective as a preventive measure, when administered at an early stage before Alzheimer's pathology appears, as well as after disease symptoms have begun to appear.

 

"Early intervention with MW-151 in an Alzheimer's mouse model reduced the glial activation and proinflammatory cytokine overproduction, which resulted in improvement in neurologic outcomes," said Van Eldik. "The neurological outcomes included protection against the loss of critical nerve cell proteins and functional damage associated with learning and memory impairments."

 

In addition, the drug showed efficacy either before or after Alzheimer's disease was apparent, but was more effective when it was given before the disease was too far advanced, said Van Eldik. "The data support the hypothesis that selectively attenuating certain aspects of dysregulated brain inflammation is beneficial, especially when used early in the disease progression," she said.  "The outcomes suggest that therapeutic strategies targeting this pathological process have the potential to attenuate disease onset and progression."

In other words, administering the drug MW-151 early in the progression of Alzheimer's disease in an animal model resulted in improved outcomes, suggesting that administration of this drug before Alzheimer's symptoms are readily apparent may be a promising therapeutic strategy.  

 

Alzheimer’s disease is the sixth-leading cause of death in the United States, yet it is the only disease among the top 10 killers without a way to prevent, cure or slow its progression. The disease kills more people than diabetes, as well as more people than breast cancer and prostate cancer combined. The recent National Alzheimer’s Project Act clearly defines the rapidly growing nature of the problem and is the foundation for an evolving national plan to address this critical health and economic crisis.  Part of the national effort is to test explicit hypotheses about new disease modifying therapeutic strategies. 

 

Alzheimer's disease is a progressive disease that slowly destroys brain function, leading to memory impairments, difficulties with language and decision-making and eventually the inability to engage in normal activities of daily living and self care. The root causes of Alzheimer's are not understood. However, a rapidly growing body of experimental data and clinical observations on patients raise the possibility that unregulated brain inflammation, termed neuroinflammation, is a factor in susceptibility of disease onset and a contributor to disease progression. 

 

Regardless of neuroinflammation’s exact role, a prevailing hypothesis is that targeting of proinflammatory cytokine overproduction in the brain might be a useful therapeutic strategy to add to the armamentarium of emerging interventions. The primary brain cell target for such a disease modifying strategy would be glia, cells in the brain that produce proinflammatory cytokines and other innate immunity responses to injury or disease progression.  Glial cells normally cooperate with the nerve cells to keep the brain operating smoothly.  When an injury or change in the brain occurs, the glial cells mount a beneficial inflammation response to fight off the insult and restore the brain to its proper functioning. This beneficial process sometimes gets out of balance and the inflammation becomes too strong or does not shut off on schedule.

 

In AD, glial cells are over-activated and produce detrimental inflammatory molecules, which include the small proteins called proinflammatory cytokines, that contribute to nerve cell dysfunction or death. Drugs that selectively target cytokine up-regulation in glia are logical first attempts at this therapeutic strategy.

 

MEDIA CONTACT: Allison Elliott, allison.elliott@uky.edu

 

dsc_2763_vaneldiklabphoto2012.jpg
September
 
1
Employee Educational Assistance Award
Labor Day - Academic Holiday
Mon
2
Employee Educational Assistance Award
Internship Info Session
Student/Faculty/Staff Mixer
Tue
3
Employee Educational Assistance Award
LNFS Presents: The Wolf of Wall Street
Last Day to Add a Class
Last Day to Drop a Course with 80% Refund
UK Volunteer Fair
Wed
4
LNFS Presents: Children of Men
LNFS Presents: How To Train Your Dragon 2
Black and Latino Male Initiative
Advance Your Swagger: A Night with Fonzworth Bentely
Thu
5
Kentucky Volleyball vs. Northern Iowa
Kentucky Volleyball vs. USC
LNFS Presents: Spirited Away
LNFS Presents: Mulan
Fri
6
Free Saturday Swing Dance Lessons
Kentucky Football vs. Ohio
#maxfest (Ukirklex Campus Ministry)
Kentucky Volleyball vs. Creighton
Lets Swing Dance!
Sat
7
Kentucky Women's Soccer vs. Morehead State
Sun
8
Diversity Organization's Council
Kosher/Soul? (Jewish, African American & Appalachian culture Fuse)
Mon
9
Working Moms Connection
Job Club - Job Search Strategies for Fall
Rock Star Professionalism Series
Tue
10
Massage on the Go
College: Do the Right Thing- A conversation with Dr. Smith
The Future of Islam
LNFS Presents: Fight Club
Wed
11
9/11 Vigil
UKNABJ presents: Ferguson, Missouri: A look at media, politics and black youth in the U.S.
LNFS Presents: Mr & Mrs Smith
Duo Damiana, Molly Barth and Dieter Hennings
LNFS Presents: 22 Jump Street
Thu
12
LNFS Presents: Searching For Sugarman
LNFS Presents: Sin City
Fri
13
Free Saturday Swing Dance Lessons
Men's Soccer vs. ETSU
Sat
14
Kentucky Women's Soccer vs. Pepperdine
Sun
15
Kentucky Week Farmer's MarCat and Craft Fair
Majestic U.N.I.T.Y.
Mon
16
Justice Delayed not Justice Denied: A Talk with Dough Jones
PRHBTN Gallery Reception and Concert
Men's Soccer vs. Xavier
Chellgren Seminar Series: Buck Ryan
Tue
17
Internship Info Session
Last Day to Drop a Course Without Appearing on Transcript
Caregiver Support Group
LNFS Presents: The Immigrant
Big Blue Commonwealth
Wed
18
LNFS Presents: Watermark
LNFS Presents: X-Men: Days of Future Past
Ryan Gardner Guest Trumpet Recital
Kentucky Volleyball vs. Lipscomb
Thu
19
LNFS Presents: A Band Called Death
LNFS Presents: Prisoners
The Case for Fossil Fuels-PEIK Seminar
Men's Soccer vs. Furman
Fri
20
Rock Climbing @ Red River Gorge
College of Pharmacy Open House
Kentucky Volleyball vs. Xavier
Sat
21
 
Sun
22
Diana Ferrus: 'Writing poetry has allowed me to live': Cultural Resistance in South Africa
Kentucky Law Schools Forum
Mon
23
Pinterest Party
University of Kentucky Chamber Winds
Employer Showcase
Job Club - 10 Questions to Ask Prior to Starting a Business
Men's Soccer vs. Lousville
Tue
24
Employer Showcase
Last Day to Drop a Course with 50% Refund
UK Elder Care Lunch & Learn
BPH Open House
Documentary Film Screening - Heaven + Earth + Joe Davis
LNFS Presents: Saving Mr. Banks
Wed
25
LNFS Presents: Culture Jam
LNFS Presents: Maleficent
¡Baila!
Thu
26
LNFS Presents: Ponyo
LNFS Presents: The Little Mermaid
Opening Night Bohemiam Festival
White Water Rafting @ Chattooga River
Women's Soccer vs. Mississippi State
Fri
27
White Water Rafting @ Chattooga River
Kentucky Football vs. Vanderbilt
Free Saturday Swing Dance Lessons
Green Apple Day of Service: "Pick It Up"
Garba Night
Swing Dancing!
Sat
28
White Water Rafting @ Chattooga River
UK Chorale
Dirty Dancing Trip
Kentucky Women's Soccer vs. Auburn
Sun
29
 
Mon
30
#TrendingTopics: Immigration Reform
Apollo Duo - Flute and Percussion Guest Recital
Tue
 
 
 
 

Tue, 09/23/2014

Repeats every day until Wed Sep 24 2014 .
Tue, 09/23/2014

Reset Page